T0	Participants 11 116	children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy
T1	Participants 258 472	children who were treated with chemotherapy and radiotherapy on the Children's Cancer Group (CCG) high-grade glioma protocol (CCG-945) who were diagnosed with low-grade gliomas on post hoc central pathologic review
T2	Participants 555 667	Between 1985 and 1991, 250 children with institutionally classified high-grade gliomas were enrolled on CCG-945.
T3	Participants 668 723	Patients older than 24 months with intracranial lesions
T4	Participants 878 936	younger patients and those with primary spinal cord tumors
T5	Participants 1071 1144	low-grade glioma in 70 patients, who were the focus of the current study.
T6	Participants 1172 1258	42 males and 28 females (median age, 7.7 years) with a median follow-up of 10.4 years.